Back4D Molecular Therapeutics Overview
4D Molecular Therapeutics Inc

4D Molecular Therapeutics Discounted Cash Flow

DCF Analysis for FDMT.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$2.31

Current Fair Value

$2.31
75.0% Downside

Overvalued by 75.0% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading